Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-014711

Chief Executive Officer sold 5,675 shares at $196.61 ($1,115,745)

  • Chief Executive Officer acquired 5,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farrell Michael J. Chief Executive Officer 2022-05-16 Option exercise +5,675 $57.76 $327,788 410,935 D
Farrell Michael J. Chief Executive Officer 2022-05-16 Sale −5,675 $196.61 $1,115,745 405,260 D
Derivatives
Farrell Michael J. Chief Executive Officer 2022-05-16 Option exercise · ResMed Common Stock Options −5,675 105,615 D
Open-market sales · 5,675 sh · avg $196.61 · $1,115,745
Loading xslF345X03/form4.xml…